文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症心肌病临床诊断评分体系的建立与评价

[Establishment and evaluation of clinical diagnostic scoring system for septic cardiomyopathy].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论脓毒症患者中,年龄≥87岁、NT-proBNP≥3000 ng/L、呼吸频率≥30次/分、乳酸≥3 mmol/L、SOFA≥10分五项指标构建的6分评分体系,以3分为界诊断脓毒症心肌病AUC 0.833、敏感度71.4%、特异度86.7%。

该前瞻性队列研究纳入2019年1月至2020年12月中国康复研究中心急诊科收治的脓毒症及脓毒性休克患者147例,脓毒症心肌病(SCM)发生率为28.6%(42/147)。通过单因素及多因素Logistic回归筛选独立危险因素并建立临床诊断评分体系:年龄≥87岁(1分)、NT-proBNP≥3000 ng/L(1分)、呼吸频率≥30次/分(1分)、乳酸≥3.0 mmol/L(1分)、SOFA≥10分(2分),总分6分。ROC曲线分析显示,以3分为诊断界值时AUC为0.833(95%CI 0.755-0.910,P<0.001),敏感度71.4%,特异度86.7%。作者认为该评分体系对SCM诊断效能良好,有助于临床医生早期识别SCM。

要点

  • 评分体系共6分:年龄≥87岁1分、NT-proBNP≥3000 ng/L 1分、呼吸频率≥30次/分1分、乳酸≥3.0 mmol/L 1分、SOFA≥10分2分。
  • 以3分为界诊断SCM的AUC为0.833(95%CI 0.755-0.910,P<0.001),敏感度71.4%,特异度86.7%。
  • 多因素分析中SOFA≥10分的OR为8.693(95%CI 2.541-29.742,P=0.001),是权重最高的独立危险因素。
  • 该队列脓毒症患者SCM发生率为28.6%(42/147)。
  • 其他独立危险因素:年龄≥87岁OR=3.491(95%CI 1.371-8.893,P=0.009);NT-proBNP≥3000 ng/L OR=2.708(95%CI 1.093-6.711,P=0.031);呼吸频率≥30次/分OR=3.404(95%CI 1.356-8.541,P=0.009);

适用人群与场景

  • 2019年1月至2020年12月中国康复研究中心急诊科收治的脓毒症及脓毒性休克患者。
  • 入院时记录基线信息、病史、心率、平均动脉压、体温和呼吸频率。
  • 入院24小时内及入院第7天行经胸超声心动图检查。

诊断标准与关键阈值

  • 脓毒症心肌病临床诊断评分体系总分6分:年龄≥87岁1分、NT-proBNP≥3000 ng/L 1分、呼吸频率≥30次/分1分、乳酸≥3.0 mmol/L 1分、SOFA≥10分2分。
  • 评分体系诊断SCM的cut-off值为3分,AUC 0.833(95%CI 0.755-0.910,P<0.001),敏感度71.4%,特异度86.7%。
  • 连续指标cut-off值由ROC曲线确定并结合临床资料离散化。

研究设计与关键结果

  • 研究类型:前瞻性队列研究;样本量147例;单中心(中国康复研究中心急诊科);人群为脓毒症及脓毒性休克患者。
  • SCM发生率为28.6%(42/147)。
  • 单因素Logistic回归显示SCM危险因素:连续指标包括年龄、NT-proBNP、呼吸频率、平均动脉压、乳酸、NRS2002、SOFA、APACHE II;离散指标包括休克、使用血管活性药物、冠心病史、急性肾损伤(AKI)。
  • 多因素Logistic回归(连续指标离散化后)显示独立危险因素:年龄≥87岁OR=3.491(95%CI 1.371-8.893,P=0.009);NT-proBNP≥3000 ng/L OR=2.708(95%CI 1.093-6.711,P=0.031);呼吸频率≥30次/分OR=3.404(95%CI 1.356-8.541,P=0.009);乳酸≥3 mmol/L OR=3.572(95%CI 1.460-8.739,P=0.005);SOFA≥10分OR=8.693(95%CI 2.541-29.742,P=0.001)。
  • 评分体系以3分为界诊断SCM:AUC 0.833(95%CI 0.755-0.910,P<0.001),敏感度71.4%,特异度86.7%。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该临床诊断评分体系对SCM诊断效能良好,有助于临床医生早期识别SCM。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To establish a clinical diagnostic scoring system for septic cardiomyopathy (SCM) and evaluate its diagnostic efficacy.

METHODS: A prospective cohort study was performed. Patients with sepsis and septic shock admitted to the department of emergency of China Rehabilitation Research Center were enrolled from January 2019 to December 2020. The baseline information, medical history, heart rate (HR), mean arterial pressure (MAP), body temperature and respiratory rate (RR) on admission were recorded. Laboratory indexes such as white blood cell count (WBC), hypersensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and blood lactic acid (Lac) were measured. Transthoracic echocardiography was conducted within 24 hours and on the 7th after admission. Sequential organ failure assessment (SOFA) score, acute physiology and chronic health evaluation II (APACHE II), and nutritional risk screening 2002 scale (NRS2002) were also assessed. The patients were divided into two groups according to whether SCM occurred or not. The risk factors of SCM were screened by univariate and multivariate Logistic regression. The cut-off value of continuous index was determined by receiver operator characteristic curve (ROC curve) and discretized concerning clinical data. The regression coefficient β was used to establish the corresponding score, and the clinical diagnostic score system of SCM was established. The diagnostic value of the model was evaluated by ROC curve.

RESULTS: In total, 147 patients were enrolled in the study and the incidence of SCM was 28.6% (42/147). Univariate Logistic regression analysis showed the risk factors of SCM included: (1) continuous indicators: age, NT-proBNP, RR, MAP, Lac, NRS2002, SOFA, APACHE II; (2) discrete indicators: shock, use of vasoactive drugs, history of coronary heart disease, acute kidney injury (AKI). Multivariate Logistic regression analysis after discretization of above continuous index showed that age ≥ 87 years old, NT-proBNP ≥ 3 000 ng/L, RR ≥ 30 times/min, Lac ≥ 3 mmol/L and SOFA ≥ 10 points were independent risk factors for SCM [age ≥ 87 years: odds ratio (OR) = 3.491, 95% confidence interval (95%CI) was 1.371-8.893, P = 0.009; NT-proBNP ≥ 3 000 ng/L: OR = 2.708, 95%CI was 1.093-6.711, P = 0.031; RR ≥ 30 times/min: OR = 3.404, 95%CI was 1.356-8.541, P = 0.009; Lac ≥ 3 mmol/L: OR = 3.572, 95%CI was 1.460-8.739, P = 0.005; SOFA ≥ 10 points: OR = 8.693, 95%CI was 2.541-29.742, P = 0.001]. The clinical diagnostic score system of SCM was established successfully, which was composed of age ≥ 87 years old (1 point), NT-proBNP ≥ 3 000 ng/L (1 point), RR ≥ 30 times/min (1 point), Lac ≥ 3.0 mmol/L (1 point), SOFA ≥ 10 points (2 points), and the total score was 6 points. ROC curve analysis showed the cut-off value of the scoring system for diagnosing SCM was 3 points, the area under ROC curve (AUC) was 0.833, 95%CI was 0.755-0.910, P < 0.001, with the sensitivity of 71.4%, and specificity of 86.7%.

CONCLUSIONS: The clinical diagnostic scoring system has good diagnostic efficacy for SCM and contributes to early identification of SCM for clinicians.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Shang N, Liu H, Wang N, et al. [Establishment and evaluation of clinical diagnostic scoring system for septic cardiomyopathy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 35131004. doi:10.3760/cma.j.cn121430-20210618-0913

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。